각막이식 시장 규모, 점유율, 성장 분석 : 유형별, 적응증별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Corneal Transplant Market size was valued at USD 526.74 Million in 2024 and is poised to grow from USD 566.24 Million in 2025 to USD 1009.88 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

Market insights reveal that corneal transplants play a crucial role in treating keratoconus, with 10-15% of patients eventually requiring this surgical intervention. This highlights the essential nature of corneal implants in managing the condition, which affects a significant number of individuals globally. Furthermore, corneal blindness is recognized as a major public health issue, being the third leading cause of blindness after glaucoma and cataracts. Approximately 10 million people are affected worldwide, emphasizing the urgent need for effective solutions in corneal health. The increasing awareness of these issues is likely to drive demand for corneal transplant procedures, positioning them as a vital component in the ophthalmology market and underscoring the need for continued advancements in treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the increasing prevalence of ocular diseases and conditions that lead to vision impairment and corneal blindness. As factors such as the aging population, rising incidence of diabetes, and environmental influences contribute to a growing number of patients requiring corneal transplants, there is an enhanced demand for effective surgical solutions. Additionally, advancements in surgical techniques and post-operative care have improved transplant success rates, further encouraging patients and healthcare providers to pursue corneal transplant procedures. This heightened awareness and improved outcomes are vital in driving market growth.

Restraints in the Corneal Transplant Market

One significant market restraint for the global corneal transplant market is the shortage of donor corneas. The limited availability of suitable donor tissues can hinder the volume of successful transplant surgeries, impacting patient outcomes and overall market growth. Furthermore, stringent regulations and ethical considerations surrounding organ donation can complicate the procurement process. This scarcity leads to prolonged waiting periods for patients, contributing to dissatisfaction and potentially worsening visual impairment. Additionally, the high costs associated with corneal transplantation procedures and follow-up care may deter patients and healthcare providers from pursuing these lifesaving interventions, further constraining market expansion.

Market Trends of the Corneal Transplant Market

The corneal transplant market is experiencing remarkable growth driven by a confluence of factors that enhance the demand for innovative medical solutions. Technological advancements in corneal implants have significantly improved their effectiveness in treating a variety of eye disorders, making them a preferred choice for both patients and healthcare providers. Additionally, the rising geriatric population, with increasing susceptibility to eye conditions such as Fuchs' dystrophy, further fuels market expansion. This demographic shift not only heightens the need for corneal transplants but also fosters investments in research and development, leading to better treatment outcomes and greater accessibility in ophthalmology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2026-2033)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2026-2033)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2026-2033)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations